Mike Flint

7.2k total citations · 2 hit papers
56 papers, 4.0k citations indexed

About

Mike Flint is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Mike Flint has authored 56 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 26 papers in Epidemiology and 17 papers in Hepatology. Recurrent topics in Mike Flint's work include Viral Infections and Outbreaks Research (20 papers), Viral Infections and Vectors (19 papers) and Hepatitis B Virus Studies (17 papers). Mike Flint is often cited by papers focused on Viral Infections and Outbreaks Research (20 papers), Viral Infections and Vectors (19 papers) and Hepatitis B Virus Studies (17 papers). Mike Flint collaborates with scholars based in United States, United Kingdom and France. Mike Flint's co-authors include Jane A. McKeating, Martin D. Ryan, Charles M. Rice, Shoshana Levy, Carine Logvinoff, Christina F. Spiropoulou, Jie Zhang, Mayla Hsu, Cecilia Cheng‐Mayer and Catherine Maidens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Mike Flint

55 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

2003 641 citations Mike Flint, Jane A. McKeating et al. Proceedings of the National Academy of Sciences profile →
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

2017 361 citations Michael K. Lo, Robert Jordan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike Flint United States	35	2.0k	1.8k	1.2k	866	679	56	4.0k
Chao Lin United States	23	3.2k 1.6×	2.2k 1.2×	1.3k 1.1×	694 0.8×	1.0k 1.5×	39	4.3k
Dimitri Lavillette France	38	2.2k 1.1×	2.2k 1.2×	929 0.8×	893 1.0×	1.4k 2.1×	74	5.2k
Marlène Dreux France	32	2.5k 1.3×	2.6k 1.4×	694 0.6×	732 0.8×	1.2k 1.7×	51	4.8k
Troels K. H. Scheel Denmark	32	2.6k 1.3×	2.3k 1.3×	653 0.6×	548 0.6×	945 1.4×	54	3.9k
Koji Ishii Japan	31	2.1k 1.1×	1.5k 0.9×	928 0.8×	413 0.5×	767 1.1×	118	3.4k
Philippe Roingeard France	42	1.9k 1.0×	2.2k 1.2×	951 0.8×	388 0.4×	1.1k 1.6×	146	4.6k
Susan L. Uprichard United States	27	2.8k 1.4×	2.9k 1.6×	504 0.4×	410 0.5×	850 1.3×	72	4.3k
Heidi E. Drummer Australia	34	1.6k 0.8×	2.0k 1.1×	556 0.5×	794 0.9×	496 0.7×	99	3.3k
Zijiang Zhao Japan	14	2.3k 1.1×	2.8k 1.6×	436 0.4×	402 0.5×	925 1.4×	17	4.1k
Hiroshi Yoshikura Japan	31	1.7k 0.9×	1.9k 1.0×	674 0.6×	541 0.6×	1.3k 1.9×	223	4.5k

Countries citing papers authored by Mike Flint

Since Specialization

Citations

This map shows the geographic impact of Mike Flint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Flint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Flint more than expected).

Fields of papers citing papers by Mike Flint

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Flint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Flint. The network helps show where Mike Flint may publish in the future.

Co-authorship network of co-authors of Mike Flint

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Flint. A scholar is included among the top collaborators of Mike Flint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Flint. Mike Flint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kelly, Jamie A., Laura K. McMullan, Payel Chatterjee, et al.. (2025). Mechanisms of action of repurposed Ebola virus antivirals – the roles of phospholipidosis and cholesterol homeostasis. Antiviral Research. 238. 106167–106167. 1 indexed citations

Shrivastava-Ranjan, Punya, Jamie A. Kelly, Laura K. McMullan, et al.. (2025). Evaluating Neutralizing Antibodies in Hantavirus-Infected Patients Using Authentic Virus and Recombinant Vesicular Stomatitis Virus Systems. Viruses. 17(5). 723–723.

Kelly, Jamie A., Payel Chatterjee, M. Harley Jenks, et al.. (2024). Identification of a macrocyclic compound targeting the lassa virus polymerase. Antiviral Research. 228. 105923–105923. 3 indexed citations

Lo, Michael K., Shilpi Jain, Katherine Davies, et al.. (2024). Optimization of Bangladesh and Malaysian genotype recombinant reporter Nipah viruses for in vitro antiviral screening and in vivo disease modeling. Antiviral Research. 231. 106013–106013. 4 indexed citations

Shrivastava-Ranjan, Punya, Payel Chatterjee, Joel M. Montgomery, et al.. (2023). Development of a novel minigenome and recombinant VSV expressing Seoul hantavirus glycoprotein-based assays to identify anti-hantavirus therapeutics. Antiviral Research. 214. 105619–105619. 3 indexed citations

Lo, Michael K., Punya Shrivastava-Ranjan, Payel Chatterjee, et al.. (2021). Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524). Microbiology Spectrum. 9(3). e0153721–e0153721. 29 indexed citations

Chatterjee, Payel, Punya Shrivastava-Ranjan, Mike Flint, et al.. (2021). Design, synthesis and biological evaluation of 2-substituted-6-[(4-substituted-1-piperidyl)methyl]-1H-benzimidazoles as inhibitors of ebola virus infection. European Journal of Medicinal Chemistry. 214. 113211–113211. 10 indexed citations

Welch, Stephen R., Jessica R. Spengler, Payel Chatterjee, et al.. (2021). Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform. Viruses. 13(7). 1255–1255. 7 indexed citations

Lo, Michael K., César G. Albariño, Jason K. Perry, et al.. (2020). Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases. Proceedings of the National Academy of Sciences. 117(43). 26946–26954. 45 indexed citations

10.

Flint, Mike, Payel Chatterjee, David L. Lin, et al.. (2019). A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus. Nature Communications. 10(1). 285–285. 48 indexed citations

11.

Chatterjee, Payel, Mike Flint, Damjan Makuc, et al.. (2019). Probing the Effects of Pyrimidine Functional Group Switches on Acyclic Fleximer Analogues for Antiviral Activity. Molecules. 24(17). 3184–3184. 15 indexed citations

12.

McMullan, Laura K., Mike Flint, Ayan K. Chakrabarti, et al.. (2019). Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis. The Lancet Infectious Diseases. 19(9). 1023–1032. 34 indexed citations

13.

Welch, Stephen R., Florine E. M. Scholte, Mike Flint, et al.. (2017). Identification of 2′-deoxy-2′-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. Antiviral Research. 147. 91–99. 51 indexed citations

14.

Welch, Stephen R., Lisa Wiggleton Guerrero, Ayan K. Chakrabarti, et al.. (2016). Lassa and Ebola virus inhibitors identified using minigenome and recombinant virus reporter systems. Antiviral Research. 136. 9–18. 57 indexed citations

15.

Mohr, Emma L., Laura K. McMullan, Michael K. Lo, et al.. (2015). Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antiviral Research. 120. 40–47. 57 indexed citations

16.

Howe, Anita Y. M., Robert Ralston, Robert A. Chase, et al.. (2007). [432] FAVORABLE CROSS-RESISTANCE PROFILE OF TWO NOVEL HEPATITIS C VIRUS INHIBITORS, SCH-503034 AND HCV-796, AND ENHANCED ANTI-REPLICON ACTIVITY MEDIATED BY THE COMBINED USE OF BOTH COMPOUNDS. Journal of Hepatology. 46. S165–S165. 5 indexed citations

17.

Flint, Mike, Elizabeth R. Quinn, & Shoshana Levy. (2001). IN SEARCH OF HEPATITIS C VIRUS RECEPTOR(S). Clinics in Liver Disease. 5(4). 873–893. 38 indexed citations

18.

Flint, Mike & Jane A. McKeating. (2000). The role of the hepatitis C virus glycoproteins in infection. Reviews in Medical Virology. 10(2). 101–117. 65 indexed citations

19.

Ryan, Martin D., Sean J. Monaghan, & Mike Flint. (1998). Virus-encoded proteinases of the Flaviviridae.. Journal of General Virology. 79(5). 947–959. 64 indexed citations

20.

Donnelly, Michelle, Martin D. Ryan, Mike Flint, David Gani, & Sean J. Monaghan. (1997). The cleavage activities of aphthovirus and cardiovirus 2A proteins.. Journal of General Virology. 78(1). 13–21. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact